Multivitamins
Last reviewed October 2026 · Based on 12 studies
Bottom line
A daily multivitamin may slightly improve memory in older adults and slowed two DNA-based aging clocks in one trial, but the evidence for both is limited and mixed. Large trials found no effect on heart disease, and cancer results are mixed. The largest trial reported no safety concerns, but beta carotene supplements were linked to more lung cancer in people at high risk of it.
What it helps with
- Helps memory and thinking in older adults — Mixed results, evidence grade C (Limited). Two COSMOS trials and a meta-analysis of COSMOS substudies found small benefits, while the Physicians' Health Study II found none; downgraded for inconsistency, and the COSMOS substudies are not independent.
- Lowers cancer risk — Mixed results, evidence grade B (Moderate). Systematic review of trials and two large RCTs; one found a small reduction and the newest found none; downgraded once for inconsistency.
- Lowers heart disease risk — No effect, evidence grade A (Strong). Two large RCTs and a meta-analysis agree on no effect; no downgrade.
- Slows biological aging — Benefit, evidence grade C (Limited). One prespecified two-year RCT substudy (958 people) plus a smaller metabolomic RCT; surrogate aging markers, downgraded once; significant on 2 of 5 clocks.
What it is
A multivitamin-multimineral (MVM) pill combines many vitamins and minerals in one daily dose. Multivitamin preparations are the most common dietary supplement, taken by at least one-third of US adults [1]. The COSMOS trials tested one product, Centrum Silver, taken once a day [2].
What the research says
Memory and thinking. In COSMOS-Mind, 2,262 older adults took a daily multivitamin-mineral or placebo for three years; global cognition improved slightly more on the multivitamin (0.07 standard units, 95% CI 0.02 to 0.12) [3]. A meta-analysis of three COSMOS cognitive substudies found a benefit for global cognition and for episodic memory; the authors said the global cognition effect was about equal to two years of slower cognitive aging [4]. In the Physicians' Health Study II, 5,947 male physicians aged 65 and older took a multivitamin for up to 12 years and showed no difference in cognitive change [5].
Cancer. In 14,641 male physicians followed for 11 years, a daily multivitamin modestly reduced total cancer (hazard ratio 0.92, 95% CI 0.86 to 0.998), but not prostate or colorectal cancer individually [1]. In COSMOS-Web, 21,442 adults took it for 3.6 years and total invasive cancer was not significantly reduced (hazard ratio 0.97, 95% CI 0.86 to 1.09) [6]. A systematic review of trials for the US Preventive Services Task Force found a small reduction in cancer incidence with multivitamin use, while noting the limits of the evidence [7].
Heart disease. In the Physicians' Health Study II, 14,641 men were followed for about 11 years, and the multivitamin did not reduce major cardiovascular events (hazard ratio 1.01, 95% CI 0.91 to 1.10) [8]. COSMOS-Web found the same for its combined heart outcome (hazard ratio 0.98) [6]. A 2018 meta-analysis of trials and cohorts found no association with cardiovascular death (relative risk 1.00) [9].
Biological aging. In a prespecified two-year substudy of 958 COSMOS participants, the multivitamin slowed the rise of two epigenetic clocks, PCGrimAge and PCPhenoAge [2]. A smaller metabolomic analysis of 399 people found small rises in omega-3 fatty acids and DHA, but its aging clocks were not statistically significant [10].
Doses used in studies
The COSMOS trials used one daily multivitamin-mineral pill (Centrum Silver) against placebo [2]. Trial length ranged from two years for the aging clocks [2] to 3.6 years in COSMOS-Web [6], three years in COSMOS-Mind [3] and about 11 to 12 years in the Physicians' Health Study II [8][5].
Safety and interactions
- Side effects: COSMOS-Web reported no safety concerns with the daily multivitamin [6].
- Beta carotene: separate beta carotene supplements were linked to more lung cancer in people at high risk of it, and to more cardiovascular deaths [7].
- Single vitamins: the same review linked vitamin A to hip fracture, vitamin E to hemorrhagic stroke, and vitamin C and calcium to kidney stones [7].
- Upper limits, pregnancy and medicine interactions: the trial abstracts read for this page did not report upper intake limits, pregnancy data or interactions with medicines. Ask a doctor or pharmacist, especially if you take medicines or have kidney disease.
Caveats and open questions
The trials mostly enrolled healthy, well-nourished older adults, and the authors of the Physicians' Health Study II noted that doses may be too low, or the population too well-nourished, to benefit [5]. Cancer and cognition results disagree between trials [1][6][3][5]. The aging clocks are surrogate markers, and their clinical meaning is unknown [2]. Manufacturers donated pills and packaging for the COSMOS trials [2].
References
- Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial.. JAMA, 2012.
- Effects of daily multivitamin-multimineral and cocoa extract supplementation on epigenetic aging clocks in the COSMOS randomized clinical trial.. Nat Med, 2026.
- Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial.. Alzheimers Dement, 2023.
- Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS.. Am J Clin Nutr, 2024.
- Long-term multivitamin supplementation and cognitive function in men: a randomized trial.. Ann Intern Med, 2013.
- Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial.. Am J Clin Nutr, 2022.
- Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.. JAMA, 2022.
- Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.. JAMA, 2012.
- Association of Multivitamin and Mineral Supplementation and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis.. Circ Cardiovasc Qual Outcomes, 2018.
- Effects of daily multivitamin-multimineral supplementation on metabolomic profiles: 2-year findings from the COSMOS randomized clinical trial.. Geroscience, 2026.